Autopsy report · NCT01216371
Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)
Cause of deathNo reason given
Life of this trial
- Ran for about 5 years before it stopped.
- 60 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Association of Urologic Oncology (AUO)
- Sponsor type
- University, hospital or other
- Conditions
- Renal Cell Carcinoma; Pulmonary Metastases
- Interventions
- Sunitinib; Placebo
- Participants
- 60 (planned, not actual)
- Sites
- 11
- Countries
- Germany
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.